155 related articles for article (PubMed ID: 37957298)
1. The impact of COVID-19 on hospitalizations that underwent endoscopic retrograde cholangiopancreatography in the United States.
Dahiya DS; Pinnam BSM; Chandan S; Gangwani MK; Ali H; Deliwala S; Bapaye J; Aziz M; Merza N; Inamdar S; Al-Haddad M; Sharma N
Surg Endosc; 2024 Jan; 38(1):202-211. PubMed ID: 37957298
[TBL] [Abstract][Full Text] [Related]
2. Clinical outcomes and predictors for 30-day readmissions of endoscopic retrograde cholangiopancreatography in the United States.
Dahiya DS; Pinnam BSM; Chandan S; Gangwani MK; Ali H; Gopakumar H; Aziz M; Bapaye J; Al-Haddad M; Sharma NR
J Gastroenterol Hepatol; 2024 Jan; 39(1):141-148. PubMed ID: 37743640
[TBL] [Abstract][Full Text] [Related]
3. End-stage renal disease is associated with increased post endoscopic retrograde cholangiopancreatography adverse events in hospitalized patients.
Sawas T; Bazerbachi F; Haffar S; Cho WK; Levy MJ; Martin JA; Petersen BT; Topazian MD; Chandrasekhara V; Abu Dayyeh BK
World J Gastroenterol; 2018 Nov; 24(41):4691-4697. PubMed ID: 30416316
[TBL] [Abstract][Full Text] [Related]
4. Racial disparities in endoscopic retrograde cholangiopancreatography (ERCP) utilization in the United States: are we getting better?
Dahiya DS; Perisetti A; Sharma N; Inamdar S; Goyal H; Singh A; Rotundo L; Garg R; Cheng CI; Pisipati S; Al-Haddad M; Sanaka M
Surg Endosc; 2023 Jan; 37(1):421-433. PubMed ID: 35986223
[TBL] [Abstract][Full Text] [Related]
5. Temporal trend and factors associated with post-endoscopic retrograde cholangiopancreatography pancreatitis in children in the USA: a nationwide, retrospective cohort study.
Zhu R; Wu S; Xu J; Wang R; Cheng Y; Xu Y; Chen C; Wu C
Eur J Pediatr; 2023 May; 182(5):2273-2282. PubMed ID: 36872379
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of socioeconomic and healthcare disparities on same admission cholecystectomy after endoscopic retrograde cholangiopancreatography among patients with acute gallstone pancreatitis.
Chouairi F; McCarty TR; Hathorn KE; Sharma P; Aslanian HR; Jamidar PA; Thompson CC; Muniraj T
Surg Endosc; 2022 Jan; 36(1):274-281. PubMed ID: 33481109
[TBL] [Abstract][Full Text] [Related]
7. Assessment of the July effect in post-endoscopic retrograde cholangiopancreatography pancreatitis: Nationwide Inpatient Sample.
Schulman AR; Abougergi MS; Thompson CC
World J Gastrointest Endosc; 2017 Jul; 9(7):296-303. PubMed ID: 28744341
[TBL] [Abstract][Full Text] [Related]
8. Endoscopic retrograde cholangiopancreatography outcomes in inflammatory bowel disease patients: a 12-year analysis of a national database.
Deshmukh A; Desai PM; Chrusciel T; Nwankwo E; Tripathi R; Cheesman AR
Int J Colorectal Dis; 2023 May; 38(1):137. PubMed ID: 37204502
[TBL] [Abstract][Full Text] [Related]
9. Endoscopic Retrograde Cholangiopancreatography (ERCP) in Patients With Liver Cirrhosis: Analysis of Trends and Outcomes From the National Inpatient Sample Database.
Solanki S; Kichloo A; Dahiya DS; Solanki D; Singh J; Wani F; Albosta M; Ghimire S; Haq KF; Khan HMA; Jafri SM; Siddiqui MA; Zuchelli T
J Clin Gastroenterol; 2022 Aug; 56(7):618-626. PubMed ID: 34107514
[TBL] [Abstract][Full Text] [Related]
10. Decompensated cirrhosis may be a risk factor for adverse events in endoscopic retrograde cholangiopancreatography.
Inamdar S; Berzin TM; Berkowitz J; Sejpal DV; Sawhney MS; Chutanni R; Pleskow DK; Trindade AJ
Liver Int; 2016 Oct; 36(10):1457-63. PubMed ID: 26913829
[TBL] [Abstract][Full Text] [Related]
11. Temporal trends and mortality of post-ERCP pancreatitis in the United States: a nationwide analysis.
Mutneja HR; Vohra I; Go A; Bhurwal A; Katiyar V; Palomera Tejeda E; Thapa Chhetri K; Baig MA; Arora S; Attar B
Endoscopy; 2021 Apr; 53(4):357-366. PubMed ID: 32668463
[TBL] [Abstract][Full Text] [Related]
12. Pancreatic stents for the prevention of post-endoscopic retrograde cholangiopancreatography pancreatitis should be inserted up to the pancreatic body or tail.
Sugimoto M; Takagi T; Suzuki R; Konno N; Asama H; Sato Y; Irie H; Watanabe K; Nakamura J; Kikuchi H; Waragai Y; Takasumi M; Hikichi T; Ohira H
World J Gastroenterol; 2018 Jun; 24(22):2392-2399. PubMed ID: 29904246
[TBL] [Abstract][Full Text] [Related]
13. Pre- and post-procedure risk prediction models for post-endoscopic retrograde cholangiopancreatography pancreatitis.
Park CH; Park SW; Yang MJ; Moon SH; Park DH
Surg Endosc; 2022 Mar; 36(3):2052-2061. PubMed ID: 34231067
[TBL] [Abstract][Full Text] [Related]
14. The role and timing of endoscopic retrograde cholangiopancreatography in acute biliary pancreatitis without cholangitis: A nationwide analysis.
Weissman S; Sharma S; Ehrlich D; Aziz M; Bangolo A; Gade A; Thompson-Edwards A; Singla K; Venkatesh HK; Hoo Kim M; Muthineni VAB; Makrani M; Muthukumar A; Gurumurthy V; Prasad BA; Nemalikanti S; Thomas J; Kasarapu RB; Chugh R; Narayan KL; Acharya A; Pandol SJ; Tabibian JH
J Hepatobiliary Pancreat Sci; 2023 Jun; 30(6):767-776. PubMed ID: 36448275
[TBL] [Abstract][Full Text] [Related]
15. Risk factors for post-endoscopic retrograde cholangiopancreatography (ERCP) abdominal pain in patients without post-ERCP pancreatitis.
Chen MJ; Zheng RH; Cao J; Yao YL; Wang L; Zou XP
Hepatobiliary Pancreat Dis Int; 2022 Jun; 21(3):285-292. PubMed ID: 34924299
[TBL] [Abstract][Full Text] [Related]
16. Trends in the Use of Endoscopic Retrograde Cholangiopancreatography for the Management of Chronic Pancreatitis in the United States.
Clark CJ; Fino NF; Clark N; Rosales A; Mishra G; Pawa R
J Clin Gastroenterol; 2016; 50(5):417-22. PubMed ID: 26890329
[TBL] [Abstract][Full Text] [Related]
17. National trends of endoscopic retrograde cholangiopancreatography utilization and outcomes in decompensated cirrhosis.
Mehta D; Poojary P; Saha A; Kaur S; Patel S; Chawla L; Kumar A; Simoes P; Busayavalasa D; Nadkarni G; Sanaka M
Surg Endosc; 2019 Jan; 33(1):169-178. PubMed ID: 29943059
[TBL] [Abstract][Full Text] [Related]
18. Trend and Predictors of the Utilization of Endoscopic Retrograde Cholangiopancreatography in Acute Pancreatitis Hospitalizations.
Sharma A; Rakholiya JH; Madapu A; Sharma S; Jha A
Cureus; 2020 Nov; 12(11):e11420. PubMed ID: 33312816
[TBL] [Abstract][Full Text] [Related]
19. Systemic inflammatory response syndrome between 24 and 48 h after ERCP predicts prolonged length of stay in patients with post-ERCP pancreatitis: a retrospective study.
Sinha A; Cader R; Akshintala VS; Hutfless SM; Zaheer A; Khan VN; Khashab MA; Lennon AM; Kalloo AN; Singh VK
Pancreatology; 2015; 15(2):105-10. PubMed ID: 25728146
[TBL] [Abstract][Full Text] [Related]
20. Multicenter prospective cohort study of adverse events associated with biliary endoscopic retrograde cholangiopancreatography: Incidence of adverse events and preventive measures for post-endoscopic retrograde cholangiopancreatography pancreatitis.
Fujita K; Yazumi S; Matsumoto H; Asada M; Nebiki H; Matsumoto K; Maruo T; Takenaka M; Tomoda T; Onoyama T; Kurita A; Ueki T; Katayama T; Kawamura T; Kawamoto H;
Dig Endosc; 2022 Sep; 34(6):1198-1204. PubMed ID: 34963021
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]